Respiratorius is a research company focused on the development of drug candidates for the treatment of cancer and especially aggressive lymphoma. The company was originally established in 1999 as a spin-off from Lund University. The business is located in Sweden, where research is conducted in-house but also through international partners. The company is headquartered in Lund.

Quotes for Respiratorius AB

Right Now

+/-
-0.005
%
-1,89%
Latest
0.26
High
0.26
Low
0.238
Volume
2 114 042
Turnover (SEK)
525 132
Market Value (MSEK)
76,0
Time (Latest trade)

Board

CEO

  • Johan Drott

Chairperson of the Board

  • Karin Wehlin

Board

  • Anna Törner
  • Johan Drott
  • Kristina Drott

Videos

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 11,24 11,24 2022-06-28
Avanza Pension 4,84 4,84 2023-03-29
Valcuria Holding AB 3,86 3,86 2023-03-29
Ben Hayes 2,34 2,34 2023-03-29
Hans Harvig 1,72 1,72 2023-03-29
Benny Bengtsson 1,09 1,09 2023-03-29
Göran Lennart Rehn 0,99 0,99 2023-03-29
Hartmut Wiese 0,99 0,99 2023-03-29
Christian Müller 0,95 0,95 2023-03-29
Hans Mandahl 0,86 0,86 2023-03-29
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream